Historical Background
Since Krebs and Fischer (1956) discovered that the activity of an enzyme (glycogen phosphorylase) can be regulated by a reversible phosphorylation, much attention has been paid to the enzymes catalyzing these covalent modifications: the protein kinases and protein phosphatases. As opposed to protein kinases, it has taken much more time to understand the action of protein phosphatases, mainly because of their complex molecular structure and broad substrate specificities. Nevertheless, protein phosphatases are equally important in controlling biochemical pathways, adding reversibility and sensitivity to these processes.
While the first kinase (phosphorylase kinase) was isolated soon after the discovery of the concept of reversible protein phosphorylation, the biochemical isolation of the first phosphataseneeded about 20 more years: ethanol denaturation (accidently applied!)...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn JH, McAvoy T, Rakhilin SV, Nishi A, Greengard P, Nairn AC. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunit. Proc Natl Acad Sci U S A. 2007a;104:2979–84.
Ahn JH, Sung JY, McAvoy T, Nishi A, Janssens V, Goris J, et al. The B″/PR72 subunit mediates Ca2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A. Proc Natl Acad Sci U S A. 2007b;104:9876–81.
Basu S. PP2A in the regulation of cell motility and invasion. Curr Protein Pept Sci. 2011;12:3–11.
Brandt H, Capulong ZL, Lee EY. Purification and properties of rabbit liver phosphorylase phosphatase. J Biol Chem. 1975;250:8038–44.
Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science. 1992;257:1261–4.
Cheng YS, Seibert O, Klöting N, Dietrich A, Straßburger K, Fernández-Veledo S, et al. PPP2R5C couples hepatic glucose and lipid homeostasis. PLoS Genet. 2015;11:e1005561. doi:10.1371/journal.pgen.1005561.
Cundell MJ, Hutter LH, Nunes Bastos R, Poser E, Holder J, Mohammed S, et al. A PP2A-B55 recognition signal controls substrate dephosphorylation kinetics during mitotic exit. J Cell Biol. 2016;214:539–54. doi:10.1083/jcb.201606033.
Dodge-Kafka KL, Bauman A, Mayer N, Henson E, Heredia L, Ahn J, et al. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3. J Biol Chem. 2010;285:11078–86. doi:10.1074/jbc.M109.034868.
Eichhorn PJ, Creyghton MP, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta. 2009;1795:1–15. doi:10.1016/j.bbcan.2008.05.005.
Guergnon J, Godet AN, Galioot A, Falanga PB, Colle JH, Cayla X, et al. PP2A targeting by viral proteins: a widespread biological strategy from DNA/RNA tumor viruses to HIV-1. Biochim Biophys Acta. 2011;1812:1498–507. doi:10.1016/j.bbadis.2011.07.001.
Haesen D, Sents W, Ivanova E, Lambrecht C, Janssens V. Cellular inhibitors of protein phosphatase PP2A in cancer. Biomed Res India. 2012;23:197–211.
Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med. 2002;347:1593–603.
Hertz EP, Kruse T, Davey NE, López-Méndez B, Sigurðsson JO, Montoya G, et al. A conserved motif provides binding specificity to the PP2A-B56 phosphatase. Mol Cell. 2016;63:686–95. doi:10.1016/j.molcel.2016.06.024.
Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T, Lackner DH, et al. Generation of active protein phosphatase 2A is coupled to holoenzyme assembly. PLoS Biol. 2007;5:e155.
Houge G, Haesen D, Vissers LE, Mehta S, Parker MJ, Wright M, et al. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. J Clin Invest. 2015;125:3051–62. doi:10.1172/JCI79860.
Hunt T. On the regulation of protein phosphatase 2A and its role in controlling entry into and exit from mitosis. Adv Biol Regul. 2013;53:173–8. doi:10.1016/j.jbior.2013.04.001.
Ingebritsen TS, Cohen P. The protein phosphatases involved in cellular regulation. 1. Classification and substrate specificities. Eur J Biochem. 1983;132:255–61.
Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001;353:417–39.
Janssens V, Rebollo A. The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells. Curr Mol Med. 2012;12:268–87.
Janssens V, Jordens J, Stevens I, Van Hoof C, Martens E, De Smedt H, et al. Identification and functional analysis of two Ca2+-binding EF-hand motifs in the B″/PR72 subunit of protein phosphatase 2A. J Biol Chem. 2003;278:10697–706.
Janssens V, Longin S, Goris J. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci. 2008;33:113–21. doi:10.1016/j.tibs.2007.12.004.
Kirchhefer U, Brekle C, Eskandar J, Isensee G, Kučerová D, Müller FU, et al. Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates. J Biol Chem. 2014;289:33862–73.
Kolupaeva V, Janssens V. PP1 and PP2A phosphatases – cooperating partners in modulating retinoblastoma protein activation. FEBS J. 2013;280:627–43. doi:10.1111/j.1742-4658.2012.08511.x.
Kolupaeva V, Daempfling L, Basilico C. The B55α regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes. Mol Cell Biol. 2013;33:2865–78. doi:10.1128/MCB.01730-12.
Kowluru A, Matti A. Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences. Biochem Pharmacol. 2012;84:591–7. doi:10.1016/j.bcp.2012.05.003.
Krebs EG, Fischer EH. The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim Biophys Acta. 1956;20:150–7.
Lambrecht C, Haesen D, Sents W, Ivanova E, Janssens V. Structure, regulation, and pharmacological modulation of PP2A phosphatases. Methods Mol Biol. 2013;1053:283–305. doi:10.1007/978-1-62703-562-0_17.
Letourneux C, Rocher G, Porteu F. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 2006;25:727–38.
Loveday C, Tatton-Brown K, Clarke M, Westwood I, Renwick A, Ramsay E, et al. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth. Hum Mol Genet. 2015;24:4775–9. doi:10.1093/hmg/ddv182.
Low IC, Loh T, Huang Y, Virshup DM, Pervaiz S. Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity. Blood. 2014;124:2223–34. doi:10.1182/blood-2014-03-563296.
Lubbers ER, Mohler PJ. Roles and regulation of protein phosphatase 2A (PP2A) in the heart. J Mol Cell Cardiol. 2016;101:127–33. doi:10.1016/j.yjmcc.2016.11.003.
Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci. 1999;24:186–91.
Oaks J, Ogretmen B. Regulation of PP2A by sphingolipid metabolism and signaling. Front Oncol. 2015;4:388. doi:10.3389/fonc.2014.00388.
Ohama T, Brautigan DL. Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem. 2010;285:8711–8. doi:10.1074/jbc.M109.099788.
Perrotti D, Neviani P. Protein phosphatase 2A: a target for anticancer therapy. Lancet Oncol. 2013;14:e229–38. doi:10.1016/S1470-2045(12)70558-2.
Ruvolo PP. The broken “off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance. BBA Clin. 2016;6:87–99. doi:10.1016/j.bbacli.2016.08.002.
Sangodkar J, Farrington CC, McClinch K, Galsky MD, Kastrinsky DB, Narla G. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase. FEBS J. 2016;283:1004–24. doi:10.1111/febs.13573.
Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol. 2010;12:886–93. doi:10.1038/ncb2092.
Sents W, Ivanova E, Lambrecht C, Haesen D, Janssens V. The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity. FEBS J. 2013;280:644–61. doi:10.1111/j.1742-4658.2012.08579.x.
Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell. 2009;139:468–84. doi:10.1016/j.cell.2009.10.006.
Shouse GP, Nobumori Y, Panowicz MJ, Liu X. ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ-PP2A. Oncogene. 2011;30:3755–65. doi:10.1038/onc.2011.95.
Sontag JM, Sontag E. Protein phosphatase 2A dysfunction in Alzheimer’s disease. Front Mol Neurosci. 2014;7:16. doi:10.3389/fnmol.2014.00016.
Taymans JM, Baekelandt V. Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism. Front Genet. 2014;5:382. doi:10.3389/fgene.2014.00382.13.
Voronkov M, Braithwaite SP, Stock JB. Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease. Future Med Chem. 2011;3:821–33. doi:10.4155/fmc.11.47.
Waelkens E, Goris J, Merlevede W. Purification and properties of polycation-stimulated phosphorylase phosphatases from rabbit skeletal muscle. J Biol Chem. 1987;262:1049–59.
Wlodarchak N, Xing Y. PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol. 2016;51:162–84. doi:10.3109/10409238.2016.1143913.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Janssens, V. (2018). Serine/Threonine-Protein Phosphatase 2A. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101865
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_101865
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences